Immunotherapy for High Grade Gliomas: A Clinical Update and Practical Considerations for Neurosurgeons.
Sign Up to like & getrecommendations! Published in 2019 at "World neurosurgery"
DOI: 10.1016/j.wneu.2018.12.222
Abstract: The current standard of care for patients with high grade gliomas includes surgical resection, chemotherapy, and radiation; but even still the majority of patients experience disease progression and succumb to their illness within a few… read more here.
Keywords: grade gliomas; immunotherapy high; gliomas clinical; high grade ... See more keywords
ALCHEMIST: Adjuvant targeted therapy or immunotherapy for high-risk resected NSCLC.
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2020.38.15_suppl.tps9077
Abstract: TPS9077Background: ALCHEMIST (Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial) is a clinical trial platform of the National Cancer Institute that offers biomarker analysi... read more here.
Keywords: alchemist; alchemist adjuvant; targeted therapy; adjuvant targeted ... See more keywords